ReviewFrontiers in microbiology2015
Microbial production of scleroglucan and downstream processing.
Review in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 106 citations in OpenAlex.
- Dietary Microbial Polysaccharides in Food Systems: Production, Functional Properties, and Applications.Food science & nutrition · 2026Review
- Production and Characterization of Xanthan Gum from Low-Quality Dates of Different Cultivars as a Fermentation Substrate.Polymers · 2026Article
- Role of Scleroglucan Produced byMolecules (Basel, Switzerland) · 2025Article
- Applicability Domain of the Sens-Is In Vitro Assay for Testing the Skin Sensitization Potential of Rheology-Modifying Polymers.Polymers · 2025Article
- Structural and biochemical analysis of family 92 carbohydrate-binding modules uncovers multivalent binding to β-glucans.Nature communications · 2024Article
- Evaluation of the Thermal, Chemical, Mechanical, and Microbial Stability of New Nanohybrids Based on Carboxymethyl-Scleroglucan and Silica Nanoparticles for EOR Applications.Nanomaterials (Basel, Switzerland) · 2024Article
- Exploring fungal bioemulsifiers: insights into chemical composition, microbial sources, and cross-field applications.World journal of microbiology & biotechnology · 2024Review
- Experimental Investigation of the Viscosity and Stability of Scleroglucan-Based Nanofluids for Enhanced Oil Recovery.Nanomaterials (Basel, Switzerland) · 2024Article
- Carboxymethyl Scleroglucan Synthesized viaPolymers · 2024Article
- Production, Extraction, and Solubilization of Exopolysaccharides Using Submerged Cultures of Agaricomycetes.Bio-protocol · 2023Article
- A critical review on valorization of food processing wastes and by-products for pullulan production.Journal of food science and technology · 2023Review
- Research advances of microbial enhanced oil recovery.Heliyon · 2022Review
- High-Efficiency Extraction ofMolecules (Basel, Switzerland) · 2022Article
- Increasing-Aeration Strategy: a Practical Approach to Enhance the Schizophyllan Production and Improve the Operational Conditions of Schizophyllum commune Cultivation in the Stirred Tank and Bubble Column Bioreactors.Applied biochemistry and biotechnology · 2022Article
- High-Efficiency Production ofFrontiers in microbiology · 2022Article
- Optimization of scleroglucan production by Sclerotium rolfsii by lowering pH during fermentation via oxalate metabolic pathway manipulation using CRISPR/Cas9.Fungal biology and biotechnology · 2021Article
- Efficient Production of Scleroglucan byFrontiers in bioengineering and biotechnology · 2021Article
- Assimilation of Cholesterol byJournal of fungi (Basel, Switzerland) · 2020Article
- The Influence of pH on the Scleroglucan and Scleroglucan/Borax Systems.Molecules (Basel, Switzerland) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic petroleum-based polymers and natural plant polymers have the disadvantage of restricted sources, in addition to the non-biodegradability of the former ones. In contrast, eco-sustainable microbial polysaccharides, of low-cost and standardized production, represent an alternative to address this situation. With a strong global market, they attracted worldwide attention because of their novel and unique physico-chemical properties as well as varied industrial applications, and many of them are promptly becoming economically competitive. Scleroglucan, a β-1,3-β-1,6-glucan secreted by Sclerotium fungi, exhibits high potential for commercialization and may show different branching frequency, side-chain length, and/or molecular weight depending on the producing strain or culture conditions. Water-solubility, viscosifying ability and wide stability over temperature, pH and salinity make scleroglucan useful for different biotechnological (enhanced oil recovery, food additives, drug delivery, cosmetic and pharmaceutical products, biocompatible materials, etc.), and biomedical (immunoceutical, antitumor, etc.) applications. It can be copiously produced at bioreactor scale under standardized conditions, where a high exopolysaccharide concentration normally governs the process optimization. Operative and nutritional conditions, as well as the incidence of scleroglucan downstream processing will be discussed in this chapter. The relevance of using standardized inocula from selected strains and experiences concerning the intricate scleroglucan scaling-up will be also herein outlined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.